市场调查报告书
商品编码
1392175
可操纵针市场 - 按类型(斜尖柔性针、对称尖针、肌腱驱动尖)、应用(活检、肿瘤消融、疼痛管理、机器人辅助手术)、最终用途 - 全球预测,2023-2032Steerable Needles Market - By Type (Bevel-tip Flexible Needles, Symmetric-tip Needles, Tendonactuated Tips), Application (Biopsy, Tumor Ablation, Pain Management, Robotic Assisted Surgery), End-use - Global Forecast, 2023-2032 |
由于产品不断推出和政府批准,2023 年至 2032 年间,全球可转向针市场的复合CAGR将达到 6.7%。创新针设计的引入提高了精度和可操作性,推动了市场的成长。
例如,2023 年 9 月,Serpex Medical 宣布其 Compass Steerable Needles 获得美国 FDA 510(k) 批准。这些针专门设计用于在活检过程中精确进入肺内肺结节。 Serpex Medical 旨在利用可操纵仪器的潜力来提高准确性和可及性,从而推进肺癌的诊断和治疗。 Compass Steerable Needles 的批准是在 Serpex 的 Recon Steerable Sheath 最近获得批准之后获得的,这标誌着该公司创新医疗工具的连续监管里程碑。
再加上确保安全性和有效性的监管批准,这些进步吸引了寻求改善微创手术手术结果的医疗保健提供者和机构。随着新产品进入市场和监管机构认可其使用,可操纵针的市场需求不断扩大,以满足不同的医疗专业和程序。
整个可操纵针市场根据应用、最终用户和地区进行分类。
肿瘤消融领域将在 2023 年至 2032 年间经历重大发展。这些专用针能够在射频和微波消融等微创干预期间实现精确定位和治疗。医疗保健提供者越来越依赖这些创新工具来接近具有挑战性的解剖位置的肿瘤,为患者提供风险更低、恢復时间更短的微创治疗选择。随着对有效肿瘤消融技术的需求上升,在肿瘤护理和介入放射学进步的推动下,可操纵针的市场前景持续扩大。
门诊手术中心细分市场从 2023 年到 2032 年将实现显着的CAGR。这些中心优先考虑手术的精确性和效率,推动专用可操纵针的采用。这些针能够导航复杂的解剖路径并靶向特定组织,从而提高了活检、消融和药物输送的准确性。随着门诊护理的成长,对多功能、精确工具的需求不断升级,可操纵针成为提供有效、微创治疗的重要工具,有助于可操纵针市场份额的不断扩大。
欧洲可操纵针产业从 2023 年到 2032 年将呈现出值得称讚的CAGR。该地区对微创手术的倾向和介入放射学的进步推动了精确可操纵针的采用。他们能够进入具有挑战性的解剖部位进行活检、肿瘤消融和治疗,这符合欧洲改善患者治疗结果和减少住院时间的医疗保健目标。随着医疗机构优先考虑微创方法,对创新可操纵针的需求持续增长,从而塑造了整个欧洲医疗干预的不断扩大的格局。
Global Steerable Needles Market will witness 6.7% CAGR between 2023 and 2032, attributed to the continuous stream of product launches and government approvals. The introduction of innovative needle designs that offer enhanced precision and maneuverability fuels market growth.
For instance, in September 2023, Serpex Medical unveiled the clearance by the U.S. FDA under 510(k) for its Compass Steerable Needles. These needles are specifically designed for precise access to intrapulmonary lung nodules during biopsies. Serpex Medical aims to harness the potential of steerable instruments to enhance accuracy and accessibility, thereby advancing the diagnosis and treatment of lung cancer. The approval of the Compass Steerable Needles comes after the recent clearance of Serpex's Recon Steerable Sheath, marking successive regulatory milestones for the company's innovative medical tools.
Coupled with regulatory approvals that ensure safety and efficacy, these advancements attract healthcare providers and institutions seeking improved procedural outcomes in minimally invasive surgeries. As new products enter the market and regulatory bodies endorse their use, the steerable needles market demand amplifies, catering to diverse medical specialties and procedures.
The overall Steerable Needles Market is classified based on application, end-user, and region.
Tumour ablation segment will undergo significant development from 2023 to 2032. These specialized needles enable precise targeting and delivery of therapies during minimally invasive interventions, such as radiofrequency and microwave ablation. Healthcare providers increasingly rely on these innovative tools to access tumors in challenging anatomical locations, offering patients minimally invasive treatment options with reduced risks and shorter recovery times. As the demand for effective tumor ablation techniques rises, the steerable needles market outlook continues to expand, driven by advancements in oncology care and interventional radiology.
Ambulatory surgical centers segment will register a noteworthy CAGR from 2023 to 2032. These centers prioritize precision and efficiency in procedures, driving the adoption of specialized steerable needles. With their ability to navigate complex anatomical pathways and target specific tissues, these needles offer enhanced accuracy in biopsy, ablation, and drug delivery. As ambulatory care grows, the demand for versatile, precise tools escalates, positioning steerable needles as vital instruments in providing effective, minimally invasive treatments, thus contributing to the continuous expansion of the steerable needle market share.
Europe steerable needles industry will showcase a commendable CAGR from 2023 to 2032. The region's inclination towards minimally invasive procedures and advancements in interventional radiology fuels the adoption of precise steerable needles. Their ability to access challenging anatomical sites for biopsies, tumor ablation, and therapeutic delivery aligns with Europe's healthcare goals of improved patient outcomes and reduced hospital stays. As healthcare facilities prioritize minimally invasive approaches, the demand for innovative steerable needles continues to grow, shaping the expanding landscape of medical interventions across Europe.